ReP USP - Resultado da busca

Filtros : "Dougherty, Darin D." Removido: "Biological psychiatry" Limpar

Filtros

USP affiliated authors
- busatto filho, geraldo (~2)
- duran, fábio luís de souza (~2)
- miguel filho, euripedes constantino (~2)
Date published
- 2015 (~1)
- 2013 (~1)
Subjects
- antidepressivos (uso terapêutico) (1)
- biomarcadores (1)
- receptores de serotonina (1)
- regressão logística (1)
- terapia cognitiva (1)

Artigo de periodico
Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder (2015)
Hoexter, Marcelo Q.; Diniz, Juliana B.; Lopes, Antonio C.; Batistuzzo, Marcelo C.; Shavitt, Roseli G.; Dougherty, Darin D.; Duran, Fabio L. S.; Bressan, Rodrigo A.; Busatto, Geraldo F.; Miguel, Euripides C.; Sato, Joao R.
Source: Depression and Anxiety. Unidade: FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO, BIOMARCADORES, REGRESSÃO LOGÍSTICA, ÓRBITA (FISIOPATOLOGIA), TRANSTORNO OBSESSIVO-COMPULSIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Q. et al. Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder. Depression and Anxiety, v. 32, n. 12, p. 900-908, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/da.22380/epdf. Acesso em: 25 out. 2025.
APA
Hoexter, M. Q., Diniz, J. B., Lopes, A. C., Batistuzzo, M. C., Shavitt, R. G., Dougherty, D. D., et al. (2015). Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder. Depression and Anxiety, 32( 12), 900-908. doi:10.1002/da.22380
NLM
Hoexter MQ, Diniz JB, Lopes AC, Batistuzzo MC, Shavitt RG, Dougherty DD, Duran FLS, Bressan RA, Busatto GF, Miguel EC, Sato JR. Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder [Internet]. Depression and Anxiety. 2015 ; 32( 12): 900-908.[citado 2025 out. 25 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/da.22380/epdf
Vancouver
Hoexter MQ, Diniz JB, Lopes AC, Batistuzzo MC, Shavitt RG, Dougherty DD, Duran FLS, Bressan RA, Busatto GF, Miguel EC, Sato JR. Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder [Internet]. Depression and Anxiety. 2015 ; 32( 12): 900-908.[citado 2025 out. 25 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/da.22380/epdf
Artigo de periodico
Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder (2013)
Hoexter, Marcelo Q.; Dougherty, Darin D.; Duran, Fabio L. S.; Lopes, Antonio C.; Diniz, Juliana B.; Batistuzzo, Marcelo C.; Evans, Karleyton C.; Bressan, Rodrigo A.; Busatto, Geraldo F.; Miguel, Euripedes C.
Source: European Neuropsychopharmacology. Unidade: FM
Subjects: TERAPIA COMPORTAMENTAL, TERAPIA COGNITIVA, TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), RECEPTORES DE SEROTONINA, ANTIDEPRESSIVOS (USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Q. et al. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder. European Neuropsychopharmacology, v. 23, n. 7, p. 569-580, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2012.06.014. Acesso em: 25 out. 2025.
APA
Hoexter, M. Q., Dougherty, D. D., Duran, F. L. S., Lopes, A. C., Diniz, J. B., Batistuzzo, M. C., et al. (2013). Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder. European Neuropsychopharmacology, 23( 7), 569-580. doi:10.1016/j.euroneuro.2012.06.014
NLM
Hoexter MQ, Dougherty DD, Duran FLS, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder [Internet]. European Neuropsychopharmacology. 2013 ; 23( 7): 569-580.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.euroneuro.2012.06.014
Vancouver
Hoexter MQ, Dougherty DD, Duran FLS, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder [Internet]. European Neuropsychopharmacology. 2013 ; 23( 7): 569-580.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.euroneuro.2012.06.014

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2025